Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT05983770
PHASE2

Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney Transplantation

Sponsor: Eledon Pharmaceuticals

View on ClinicalTrials.gov

Summary

This study will evaluate the safety and efficacy of AT-1501 compared with tacrolimus in patients undergoing kidney transplantation.

Official title: AT-1501-K207: BESTOW: A Phase 2, Multicenter, Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney Transplantation

Key Details

Gender

All

Age Range

18 Years - 100 Years

Study Type

INTERVENTIONAL

Enrollment

127

Start Date

2023-08-30

Completion Date

2025-09-25

Last Updated

2026-07-22

Healthy Volunteers

No

Interventions

DRUG

AT-1501

IV infusions of AT-1501 20 mg/kg over 1 hour.

DRUG

Tacrolimus

Tacrolimus will be administered BID, targeting a whole blood trough concentration of 6-12 ng/mL until Month 6, and 6-8 ng/mL thereafter.

Locations (43)

University of California Los Angeles

Los Angeles, California, United States

Keck School of Medicine of USC

Los Angeles, California, United States

University of California, Irvine Medical Center

Orange, California, United States

University of California, Davis Medical Center

Sacramento, California, United States

Medstar Georgetown University Hospital

Washington D.C., District of Columbia, United States

Tampa General Hospital

Tampa, Florida, United States

Emory University Hospital

Atlanta, Georgia, United States

Augusta University

Augusta, Georgia, United States

University of Chicago

Chicago, Illinois, United States

Loyola University Medical Center

Maywood, Illinois, United States

University of Kansas Medical Center

Kansas City, Kansas, United States

Tulane Medical Center

New Orleans, Louisiana, United States

Johns Hopkins University

Baltimore, Maryland, United States

Massachusetts General Hospita;

Boston, Massachusetts, United States

Henry Ford Health System

Detroit, Michigan, United States

University of Minnesota Medical Center

Minneapolis, Minnesota, United States

Mayo Clinic

Rochester, Minnesota, United States

Washington University in St. Louis

St Louis, Missouri, United States

University of Nebraska Medical Center

Omaha, Nebraska, United States

New York University Langone Health - Tisch Hospital

New York, New York, United States

Duke University Medical Center

Durham, North Carolina, United States

University of Cincinnati Medical Center

Cincinnati, Ohio, United States

University of Pittsburgh Medical Center

Harrisburg, Pennsylvania, United States

UT Southwestern

Dallas, Texas, United States

Virginia Commonwealth University

Richmond, Virginia, United States

University of Washington Medical Center

Seattle, Washington, United States

University of Wisconsin Health

Madison, Wisconsin, United States

Royal Adelaide Hospital

Adelaide, South Australia, Australia

Fiona Stanley Hospital

Perth, Western Australia, Australia

Fundação Oswaldo Ramos - Hospital do Rim

São Paulo, Brazil

Hospital das Clínicas da Faculdade de Medicina de São Paulo

São Paulo, Brazil

St. Paul's Hospital

Vancouver, British Columbia, Canada

Groupe Hospitalier Pellegrin

Bordeaux, France

CHU Grenoble-Alpes - Hopital Nord Michallon

Grenoble, France

Centre Hospitalier Universitaire Dupuytren

Limoges, France

CHU de Toulouse - Hopital de Rangueil

Toulouse, France

CHRU Tours - Hopital Bretonneau

Tours, France

Charite Universitatsmedizin Berlin

Berlin, Germany

Hospital del Mar - Parc de Salut Mar

Barcelona, Spain

Hospital Universitari Vall d'Hebron

Barcelona, Spain

Hospital Clinic de Barcelona

Barcelona, Spain

Hospital Germans Trias i Pujol

Barcelona, Spain

Hospital Universitari de Bellvitge

Barcelona, Spain